Formycon AG (0W4N.L)

EUR 53.2

(0.95%)

Eps Summary of Formycon AG

  • Formycon AG's latest annual eps in 2023 was 4.76 EUR , up 81.68% from previous year.
  • Formycon AG's latest quarterly eps in 2024 Q2 was -0.58 EUR , down 0.0% from previous quarter.
  • Formycon AG reported an annual eps of 2.62 EUR in 2022, up 318.33% from previous year.
  • Formycon AG reported an annual eps of -1.20 EUR in 2021, down -122.22% from previous year.
  • Formycon AG reported a quarterly eps of 4.61 EUR for 2023 Q4, down 0.0% from previous quarter.
  • Formycon AG reported a quarterly eps of N/A for 2023 FY, up 81.68% from previous quarter.

Annual Eps Chart of Formycon AG (2023 - 2009)

Historical Annual Eps of Formycon AG (2023 - 2009)

Year Eps Eps Growth
2023 4.76 EUR 81.68%
2022 2.62 EUR 318.33%
2021 -1.20 EUR -122.22%
2020 -0.54 EUR -134.78%
2019 -0.23 EUR -130.67%
2018 0.75 EUR 541.18%
2017 -0.17 EUR 62.22%
2016 -0.45 EUR -807.55%
2015 0.06 EUR -36.21%
2014 0.10 EUR 112.95%
2013 -0.77 EUR -48.08%
2012 -0.52 EUR -85.71%
2011 -0.28 EUR -180.0%
2010 -0.10 EUR -141.55%
2009 -0.04 EUR 0.0%

Peer Eps Comparison of Formycon AG

Name Eps Eps Difference
Boiron SA 2.06 EUR -131.068%
Laboratorios Farmaceuticos Rovi, S.A. 3.20 EUR -48.75%
Vetoquinol SA 4.70 EUR -1.277%
Valneva SE -0.73 EUR 752.055%
AB Science S.A. -0.20 EUR 2480.0%
Nanobiotix S.A. -1.08 EUR 540.741%
PHAXIAM Therapeutics S.A. -5.00 EUR 195.2%
Vivoryon Therapeutics N.V. -1.12 EUR 525.0%
BioSenic S.A. -0.21 EUR 2366.667%
ABIVAX Société Anonyme -3.43 EUR 238.776%